Inactive Instrument

Boule Diagnostics AB Stock Nasdaq Stockholm

Equities

SE0000437402

Advanced Medical Equipment & Technology

Sales 2024 * 580M 53M Sales 2025 * 620M 56.7M Capitalization 381M 34.79M
Net income 2024 * 28M 2.56M Net income 2025 * 41M 3.75M EV / Sales 2024 * 0.79 x
Net Debt 2024 * 77.93M 7.12M Net Debt 2025 * 75.63M 6.91M EV / Sales 2025 * 0.74 x
P/E ratio 2024 *
13.2 x
P/E ratio 2025 *
9.09 x
Employees -
Yield 2024 *
2.09%
Yield 2025 *
3.47%
Free-Float 61.67%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Director of Finance/CFO - Dec. 31
Human Resources Officer - 22-09-30
Corporate Officer/Principal - 11-12-31
Members of the board TitleAgeSince
Chairman 71 20-12-31
Chairman 72 20-12-31
Director/Board Member 57 13-12-31
More insiders
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Calendar
More about the company